Results 1 to 10 of about 1,896 (179)

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire [PDF]

Tropical Medicine and Infectious Disease
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal.
Orphée Kangah, Issaka Zongo, Alassane Haro, William Yavo   +3 more
doaj   +5 more sources

Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis [PDF]

Malaria Journal
Background Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 ...
Neide Canana, Ivan Alejandro Pulido Tarquino, Sónia Enosse, Kevin Baker, Maria Rodrigues, Christian Rassi, Akashdeep Singh Chauhan, Chuks Nnaji, Baltazar Candrinho, Elisa M. Maffioli   +9 more
doaj   +5 more sources

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania [PDF]

Scientific Reports
Effectiveness of dihydroartemisinin-piperaquine (DP) as seasonal malaria chemoprevention (SMC) was assessed in Nanyumbu and Masasi Districts. Between March and June 2021, children aged 3–59 months were enrolled in a cluster randomized study.
Richard Mwaiswelo, Billy Ngasala, Frank Chaky, Fabrizio Molteni, Ally Mohamed, Samwel Lazaro, Bushukatale Samwel, Bruno P. Mmbando   +7 more
doaj   +6 more sources

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger [PDF]

Malaria Journal, 2021
Background Malaria transmission is highly seasonal in Niger. Despite the introduction of seasonal malaria chemoprevention (SMC) in the Magaria District, malaria incidence remains high, and the epidemiology of malaria in the community is not well ...
Matthew E. Coldiron, Bachir Assao, Ousmane Guindo, Nathan Sayinzoga-Makombe, Alena Koscalova, Esther Sterk, Michel Quere, Iza Ciglenecki, Ann Mumina, Salifou Atti, Céline Langendorf, Rebecca F. Grais   +11 more
doaj   +4 more sources

Seasonal malaria chemoprevention: successes and missed opportunities [PDF]

Malaria Journal, 2017
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a ...
Matthew E. Coldiron, Lorenz Von Seidlein, Rebecca F. Grais   +2 more
doaj   +5 more sources

Household-level effects of seasonal malaria chemoprevention in the Gambia [PDF]

Communications Medicine, 2023
Background In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years.
Seyi Soremekun, Bakary Conteh, Abdoullah Nyassi, Harouna M. Soumare, Blessed Etoketim, Mamadou Ousmane Ndiath, John Bradley, Umberto D’Alessandro, Teun Bousema, Annette Erhart, Marta Moreno, Chris Drakeley   +11 more
doaj   +5 more sources

Effect of seasonal malaria chemoprevention on incidence of malaria among children under five years in Kotido and Moroto Districts, Uganda, 2021: time series analysis [PDF]

Malaria Journal
Background Seasonal malaria chemoprevention (SMC) refers to monthly administration of full treatment courses of anti-malarial medicine to children
Andrew Kwiringira, Benon Kwesiga, Richard Migisha, Lilian Bulage, Daniel Kadobera, Damian Rutazaana, Julie R. Harris, Alex R. Ario, Julius Ssempiira   +8 more
doaj   +3 more sources

Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique [PDF]

Malaria Journal
Background Seasonal malaria chemoprevention (SMC) is a highly effective intervention for malaria prevention in high burden areas with seasonal transmission, historically implemented in the Sahel.
Kevin Baker, Ivan Alejandro Pulido Tarquino, Pedro Aide, Craig Bonnington, Christian Rassi, Sol Richardson, Chuks Nnaji, Arantxa Roca-Feltrer, Maria Rodrigues, Mercia Sitoe, Sonia Enosse, Caitlin McGugan, Francisco Saute, Gloria Matambisso, Baltazar Candrinho   +14 more
doaj   +3 more sources

Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) [PDF]

Malaria Journal
Background Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to
Innocent M. Ali, Isaac A. Manga, Akindeh M. Nji, Valery P. Tchuenkam, Peter Thelma Ngwa Neba, Dorothy F. Achu, Jude D. Bigoga, Babacar Faye, Cally Roper, Colin J. Sutherland, Wilfred F. Mbacham   +10 more
doaj   +3 more sources

Impact of seasonal malaria chemoprevention timing on clinical malaria incidence dynamics in the Kedougou region, Senegal. [PDF]

PLOS Glob Public Health
AbstractSeasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine is recommended by the World Health Organization since 2012 for clinical malaria prevention in children in the Sahelian region of Africa. In Senegal, SMC implementation began in 2013 and is given to children under 10 years old.
Kazanga B, Ba EH, Legendre E, Cissoko M, Fleury L, Bérard L, Diop A, Sokhna C, Danfakha F, Sagara I, Ndiaye JL, Gaudart J, Landier J.   +12 more
europepmc   +4 more sources